dobutamine has been researched along with Systolic Heart Failure in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boggu, PR; Jalani, HB; Jeon, ES; Jung, SH; Lee, YJ; Manickam, M; Pillaiyar, T; Sharma, N; Venkateswararao, E | 1 |
| Bougouin, W; Cariou, A | 1 |
| Baleine, J; Cambonie, G; de la Villéon, G; Durand, S; Jacquot, A; Milesi, C; Novais, AR; Roujeau, T | 1 |
| Bremont, C; Damy, T; Dubois-Rande, JL; Gallet, R; Guendouz, S; Gueret, P; Lim, P; Seemann, A; Ternacle, J | 1 |
| Anastasiou-Nana, M; Ikonomidis, I; Lekakis, J; Papadopoulos, C; Paraskevaidis, IA; Parissis, J; Stasinos, V | 1 |
| Lattuca, B; Roubille, F | 1 |
| Başaran, O; Biteker, M; Mert, GÖ; Mert, KU | 1 |
| Gallet, R; Lim, P; Ternacle, J | 1 |
| Dahl, JS; Egstrup, M; Faber, J; Gustafsson, I; Holmager, P; Kistorp, C; Møller, JE; Rasmussen, LM; Schou, M; Tuxen, C | 1 |
| Ikonomidis, I; Lekakis, J; Makavos, G; Paraskevaidis, IA; Parissis, J; Simitsis, P; Stasinos, V | 1 |
| Abarzúa, P; Depre, C; Dhar, SK; Malik, FI; Morgans, DJ; Shen, YT; Vatner, SF; Zhao, X | 1 |
| Andersen, MJ; Egstrup, M; Gustafsson, I; Kistorp, CN; Møller, JE; Schou, M; Tuxen, CD | 1 |
1 review(s) available for dobutamine and Systolic Heart Failure
| Article | Year |
|---|---|
Management of postcardiac arrest myocardial dysfunction.
Topics: Cardiopulmonary Resuscitation; Dobutamine; Heart Arrest; Heart Failure, Diastolic; Heart Failure, Systolic; Humans; Myocardial Ischemia | 2013 |
11 other study(ies) available for dobutamine and Systolic Heart Failure
| Article | Year |
|---|---|
Exploration of flexible phenylpropylurea scaffold as novel cardiac myosin activators for the treatment of systolic heart failure.
Topics: Animals; Cardiac Myosins; Cardiotonic Agents; Drug Design; Echocardiography; Heart; Heart Failure, Systolic; Humans; Male; Rats, Sprague-Dawley; Urea | 2017 |
[Takotsubo cardiomyopathy in an adolescent girl].
Topics: Adolescent; Cerebellum; Dobutamine; Echocardiography; Female; Heart Failure; Heart Failure, Systolic; Hematoma; Humans; Intracranial Arteriovenous Malformations; Prognosis; Rupture, Spontaneous; Takotsubo Cardiomyopathy | 2014 |
Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction.
Topics: Aged; Benzazepines; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure, Systolic; Hemodynamics; Humans; Ivabradine; Male; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Dobutamine-induced changes of multidimensional cardiac deformation predict functional capacity in patients with advanced systolic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure, Systolic; Heart Ventricles; Humans; Male; Prospective Studies; ROC Curve; Stroke Volume; Ventricular Function, Left | 2014 |
Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?
Topics: Benzazepines; Dobutamine; Female; Heart Failure, Systolic; Hemodynamics; Humans; Male; Severity of Illness Index | 2015 |
Does ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance.
Topics: Benzazepines; Dobutamine; Female; Heart Failure, Systolic; Hemodynamics; Humans; Male; Severity of Illness Index | 2014 |
Response to letter: "Does Ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance".
Topics: Benzazepines; Dobutamine; Female; Heart Failure, Systolic; Hemodynamics; Humans; Male; Severity of Illness Index | 2015 |
Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Proteins; Calcium-Binding Proteins; Cross-Sectional Studies; Diabetes Mellitus; Dobutamine; Echocardiography, Stress; Female; Fibrosis; Galectin 3; Galectins; Glucose Tolerance Test; Glycated Hemoglobin; Heart Failure, Systolic; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Predictive Value of Tests; Up-Regulation; Ventricular Function, Left | 2017 |
Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study.
Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Greece; Heart Failure, Systolic; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Prognosis; Prospective Studies; Rest; ROC Curve; Stroke Volume; Survival Rate; Ventricular Function, Left | 2017 |
Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.
Topics: Analysis of Variance; Animals; Cardiac Myosins; Consciousness; Disease Models, Animal; Dobutamine; Dogs; Drug Administration Schedule; Female; Heart Failure, Systolic; Heart Function Tests; Infusions, Intravenous; Male; Myocardial Contraction; Myocardial Infarction; Oxygen Consumption; Probability; Random Allocation; Stroke Volume; Treatment Outcome; Urea; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: comparison of echocardiographic and invasive measurements.
Topics: Aged; Cardiac Catheterization; Cardiac Output; Chronic Disease; Cohort Studies; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Doppler, Pulsed; Echocardiography, Stress; Female; Heart Failure, Systolic; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Reference Values; Risk Assessment; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2013 |